Last reviewed · How we verify

sulfadoxine-pyrimethamine with artesunate

Centers for Disease Control and Prevention · Phase 1 active Small molecule

sulfadoxine-pyrimethamine with artesunate is a Small molecule drug developed by Centers for Disease Control and Prevention. It is currently in Phase 1 development.

At a glance

Generic namesulfadoxine-pyrimethamine with artesunate
SponsorCenters for Disease Control and Prevention
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about sulfadoxine-pyrimethamine with artesunate

What is sulfadoxine-pyrimethamine with artesunate?

sulfadoxine-pyrimethamine with artesunate is a Small molecule drug developed by Centers for Disease Control and Prevention.

Who makes sulfadoxine-pyrimethamine with artesunate?

sulfadoxine-pyrimethamine with artesunate is developed by Centers for Disease Control and Prevention (see full Centers for Disease Control and Prevention pipeline at /company/centers-for-disease-control-and-prevention).

What development phase is sulfadoxine-pyrimethamine with artesunate in?

sulfadoxine-pyrimethamine with artesunate is in Phase 1.

Related